- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-06-01-2016
Pharmaceutical Executive
Pharm Exec's Top 50 Companies 2016
July 26, 2016
Features
36
6
Pharm Exec’s 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
Diversity and Inclusion: A Pharma 50 Perspective
June 23, 2016
Features
36
6
Biopharma’s diversity commitment remains a work in progress but the benefits-in measurable ROI-are increasingly clear.
Market Access in Europe: Building Health Equity Through Better Outcomes
June 20, 2016
Features
36
6
A new industry working group explores alternative drug funding options in Europe-and asks key stakeholders in the region to join the discussion.
Cancer’s Disruptive Dozen
June 17, 2016
Columns
36
6
The World Medical Innovation Forum presents its second list of breakthrough technologies-this time focused on oncology.
Design that Delivers
June 14, 2016
From the Editor
36
6
Pharm Exec explores the power of workplace aesthetic on the intangibles of culture, morale-and corporate mission-in a visit to one big Pharma's unique US headquarters.
A Digital Prescription for the Pharma Industry
June 14, 2016
Columns
36
6
How companies can better integrate valuable data across business functions to meet rising value-chain demands.
Science Meets Art: Mapping the Topography of MS
June 14, 2016
Features
36
6
A new educational and potential prognosis tool for the treatment of multiple sclerosis shows how an accessible, easy-to-see visualization of disease state can serve as the threshold for fresh clinical insight-all geared to the individual patient.
Pharma and Biotech Financial Outlook: Hazy
June 13, 2016
Features
36
6
Do recent trends in the pharma and biotech M&A and equity markets signal a temporary lull - or a permanent drop? Peter Young reports.
Promises and Pitfalls in Calculating Drug Value
June 12, 2016
Columns
36
6
There’s a stampede to relate prices to broader health benefits, but little consensus on how to do so, writes Jill Wechsler.
Europe’s ‘Radical’ Regulators Drawn Further into Pricing Debate
June 01, 2016
Columns
36
6
Top officials at EMA push the boat out on drug-pricing views.
Country Report: Italy
June 01, 2016
Special Sponsored Section
36
6
While the Italian fashion and automotive industries may steal the global thunder, another sector in Italy flourishes beneath the public’s radar. The country’s pharmaceutical industry continues to punche above its weight in many areas and has supported Italy’s national economy through many periods of weakness.
Pharmaceutical Executive, June 2016 Issue (PDF)
June 01, 2016
Issue PDF
36
6
Click the title above to open the Pharmaceutical Executive June 2016 issue in an interactive PDF format.